Shanghai Microport Endovascular Medtech Co (SHSE:688016) Total Equity: ¥4,239 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688016 Shanghai Microport Endovascular Medtech Co Ltd SHSE:688016
99 GF Score
Price ¥92.00
GF Value ¥119.83
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Microport Endovascular Medtech Co Total Equity?

Shanghai Microport Endovascular Medtech Co SHSE:688016 +3.37% 99 Total Equity is ¥4,239 Mil as of Mar. 2026. GuruFocus rates SHSE:688016 with a GF Score™ of 99/100 and a GF Value™ of ¥119.83 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shanghai Microport Endovascular Medtech Co's total equity for the quarter that ended in Mar. 2026 was ¥4,239 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shanghai Microport Endovascular Medtech Co Total Equity Historical Data

* Premium members only.

The historical data trend for Shanghai Microport Endovascular Medtech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Microport Endovascular Medtech Co Total Equity Chart

Shanghai Microport Endovascular Medtech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,522.10 1,742.63 3,863.58 3,822.47 4,098.52

Shanghai Microport Endovascular Medtech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,884.56 4,057.55 3,982.29 4,098.52 4,239.34
SHSE:688016
99GF Score
Shanghai Microport Endovascular Medtech Co Ltd SHSE:688016
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Microport Endovascular Medtech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shanghai Microport Endovascular Medtech Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=4641.152-542.632
=4,099

Shanghai Microport Endovascular Medtech Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=4793.756-554.421
=4,239

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥4,239 Mil mean?
Shanghai Microport Endovascular Medtech Co (SHSE:688016) has a Total Equity of ¥4,239 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Microport Endovascular Medtech Co and its competitors.
Is Shanghai Microport Endovascular Medtech Co's Total Equity too high?
Shanghai Microport Endovascular Medtech Co's current Total Equity is ¥4,239 Mil. Overall, Shanghai Microport Endovascular Medtech Co has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Microport Endovascular Medtech Co's Total Equity compare to ABT and SYK?
Shanghai Microport Endovascular Medtech Co's Total Equity of ¥4,239 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Microport Endovascular Medtech Co and its competitors. Shanghai Microport Endovascular Medtech Co's current Total Equity is ¥4,239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Microport Endovascular Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co (SHSE:688016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥119.83, compared to a current price of ¥92.00 — trading 23.2% below its estimated fair value. The current Total Equity is ¥4,239 Mil. Shanghai Microport Endovascular Medtech Co's overall GF Score™ is 99/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shanghai Microport Endovascular Medtech Co (SHSE:688016), the current Total Equity is ¥4,239 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Microport Endovascular Medtech Co (SHSE:688016) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co stock appears to be undervalued. The current stock price of ¥92.00 is trading 23.2% below its estimated GF Value™ of ¥119.83. GuruFocus considers Shanghai Microport Endovascular Medtech Co to be Modestly Undervalued.

Key valuation signals for SHSE:688016:

  • Total Equity: ¥4,239 Mil
  • GF Value™: ¥119.83 vs. price of ¥92.00 (23.2% below fair value)
  • GF Score™: 99/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Microport Endovascular Medtech Co Business Description

Address No. 1 Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 201318
Shanghai Microport Endovascular Medtech Co Ltd is engaged in the Research, development, production and sales of interventional medical devices for the aorta and peripheral blood vessels.
99GF Score

Get the complete analysis for SHSE:688016

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥92.00
Price
¥119.83
GF Value